| Pedro Vergne-marini, MD | |
|
1150 N Bishop Ave, Dallas, TX 75208-4168 | |
| (214) 358-2300 | |
| (214) 366-6461 |
| Full Name | Pedro Vergne-marini |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 1150 N Bishop Ave, Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194774380 | NPI | - | NPPES |
| 862034 | Other | TX | BCBS # |
| 2227295 | Other | TX | BLUELINK # |
| 4077339 | Other | TX | AETNA # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | E1436 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pedro Vergne-marini, MD 1420 Viceroy Dr, Dallas, TX 75235-2208 Ph: (214) 358-2300 | Pedro Vergne-marini, MD 1150 N Bishop Ave, Dallas, TX 75208-4168 Ph: (214) 358-2300 |
News Archive
If terrorists were to attack with a dirty bomb, medical authorities should be prepared to treat children differently than adults because their developing bodies would absorb and respond to the radiation exposure in distinct ways, according to a new study from the University of Rochester Medical Center.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
A short time ago, Swedish scientists published a paper suggesting the existence of a genetic disposition to respond to placebo, thus giving rise to debate in the media about a possible "placebo gene." In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2009; 106[46]: 751-5), Matthias Breidert and Karl Hofbauer summarize the most recent data about placebos.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed insulin nanoparticles that may one day become the basis for an oral medicine, and an alternative to insulin injections for diabetic patients.
› Verified 2 days ago
Uma B.r.k Pakkivenkata, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |